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Background: Acute liver injury occur after intraperitoneal administration of lipopolysaccharide (LPS). Oxidative
stress and release of pro-inflammatory cytokines are both implicated in the pathogenesis of LPS-induced acute
liver injury. This study investigated the ameliorative effect of fermented rooibos (Aspalathus linearis) extract on
LPS-induced acute liver injury.
Method: Major phenolic compounds in the fermented rooibos extract by HPLC-DAD, as well as the in vitro antioxidant
capacity were quantified before the start of the experiment. Male Wistar rats were randomized into 4 groups (n = 10
per group) and given either water or fermented rooibos extract for 4 weeks before LPS injection. Hepatic function
markers, including aminotransferases and lactate dehydrogenase, lipid peroxidation markers, antioxidant enzymes,
glutathione redox status, as well as cytokine levels were monitored in the rats.
Results: Injection of LPS significantly increased serum levels of alanine aminotransferase (ALT), aspartate aminotransferase
(AST) and lactate dehydrogenase (LDH). Oxidative stress, evidenced by increased thiobarbituric acid reactive substances
(TBARS) measured as malondialdehyde (MDA) in plasma and liver, and decreased glutathione redox status (GSH: GSSG
ratio) in whole blood and liver was induced in LPS-challenged rats. Furthermore, hepatic levels of pro-inflammatory
response markers TNF-α, IL-1β and IL-6 were increased significantly. Pre-feeding the fermented rooibos extract for
4 weeks decreased LPS-induced elevated levels of serum AST and LDH (significantly, p < 0.05) as well as ALT marginally.
Consuming rooibos caused an attenuation of the observed increase in plasma and hepatic MDA, decrease in whole
blood and liver GSH:GSSG ratio, as well as the changes noted in various antioxidant enzymes. The elevation in TNF-α
and IL-6 was significantly suppressed, indicating an inhibition of the induced inflammatory response by rooibos.
Conclusion: Overall, our data showed that aqueous rooibos extract attenuated LPS-induced liver injury possibly by
modulating oxidative stress and suppressing pro-inflammatory cytokines formation.
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Lipopolysaccharide (LPS), an endotoxin, is a major glyco-
lipid component of the outer cell wall of gram-negative
bacteria, made up of a polysaccharide O-chain and a
biologically active lipid-A moiety, embedded within the
bacterial membrane [1]. Endotoxemia-induced toxicity
is characterized by injury to various organs, including
liver, kidney and the brain, and it has been implicated
as a contributing factor to bacterial infection resulting
in sepsis, which is one of the major causes of morbidity
and mortality in intensive care units [2]. Most of the
toxicities observed in LPS-induced injury in the liver
and systemic circulation has been attributed to toxic
mediators produced by activated macrophages, including
cytokines, such as tumor necrosis factor-α (TNF-α),
interleukins (IL-1, IL-6, IL-8, and IL-12), other pro-
inflammatory molecules, including platelet-activating
factor, prostaglandins, as well as reactive oxygen and
nitrogen species (RONS), such as nitric oxide (NO)
and superoxide radical [3]. The systemic inflammatory
response triggered in the host by LPS is characterized by
fever, leucocytosis, thrombocytopenia, changed metabolic
responses and redox status impairment [2]. The conse-
quences of impaired intracellular redox balance includes
the generation of excessive RONS, induction of lipid
peroxidation, DNA and protein damage, depletion of
intracellular stores of endogenous antioxidants and inhib-
ition of antioxidant enzymes [4].
The involvement of oxidative stress in injury associated
with LPS suggests that dietary antioxidants may enhance
the efficacy of treatment protocols designed to mitigate
LPS-induced endotoxemia. Medicinal plants, fruits, vege-
tables, spices and teas are drawing a lot of attention
because of their demonstrated health benefits, with
scientific evidence demonstrating that phytochemicals in
fruits, vegetables, spices and teas possess a high number
of protective biological properties, including antioxidant,
anti-inflammatory and other beneficial effects [5].
Rooibos (Aspalathus linearis) (Brum f) Dahlg. (Family
Fabaceae; Tribe Crotolarieae) is a shrubby legume that is
indigenous to the mountainous area of Clanwilliam in
the Western Cape Province of South Africa. Traditionally,
it is used to make a herbal beverage that is naturally
caffeine-free, low in tannin and rich in unique polyphenolic
antioxidants [6]. Due to its rich content of different
compounds, some unique, with antioxidant and other
health properties, rooibos is gaining more attention
worldwide because of its potential for clinical uses.
Aqueous extracts of rooibos have been shown to possess
antioxidant activities in vitro [7]. In vivo evidence has
shown that aqueous rooibos extracts are able to modulate
oxidative stress by inhibiting lipid peroxidation and
augmenting the glutathione redox status in rat sperm
[8], rat liver [9] and in humans with an occupationalrisk [10] and at the risk of developing cardiovascular
diseases [11]. Immunomodulatory effects of rooibos
have been previously reported both in vitro and in vivo
[12,13], while a recent study also showed that rooibos
and two of its flavonoids (luteolin and quercetin) were
able to reduce the secretion of pro-inflammatory cytokine,
IL-6 and TNF-α using a LPS-stimulated macrophage
model [14]. However, the evaluation of the in vivo anti-
inflammatory properties of rooibos remains to be suffi-
ciently studied. Rooibos is most often consumed as a
herbal tea and therefore an aqueous (hot-water) extract of
fermented rooibos leaves and stems at a similar concen-
tration as consumed by humans traditionally were used in
this study to investigate its effectiveness in protecting
against LPS-induced hepatic injury in Wistar rats.Methods
Preparation of the aqueous rooibos extract
Fermented rooibos (superior grade) plant material was
a generous gift from Rooibos Limited (Mr Arend
Redelinghuys, Clanwilliam, South Africa). An aqueous
rooibos extract (2%, w/v), was prepared as reported
previously [15] by the addition of freshly boiled tap
water to tea leaves and stem at a concentration of 2 g/
100 mL. The mixture was allowed to stand at room
temperature for 30 minutes with constant stirring,
filtered afterwards and dispensed into water bottles.
The extract was fed to the rats ad libitum, with fresh
extract prepared every second day.Phenolic content and total antioxidant capacity of
aqueous rooibos extract
The soluble solids content of the rooibos extract was
determined gravimetrically as previously reported [15].
The total polyphenol content of the aqueous rooibos
extract was determined using the Folin Ciocalteu’s phenol
reagent according to the method described by Singleton
et al [16] and results expressed as mg gallic acid
equivalents/mg soluble solids. The flavanol content of the
aqueous rooibos extract was determined colorimetrically at
640 nm using p-dimethylaminocinnamaldehyde (DMACA)
according to the method of Treutter [17]. Results were
expressed as mg catechin standard equivalents/mg soluble
solids while the flavonol/flavones content was determined
spectrophotometrically at 360 nm and results expressed
as mg quercetin standard equivalents/mg soluble solids
[18]. The total antioxidant capacity of the rooibos extract
was assessed by measuring the oxygen radical absorbance
capacity (ORAC), trolox equivalent antioxidant capacity
(TEAC) and ferric ion reducing antioxidant power (FRAP)
according to methods described by Ou et al. [19], Re et al.
[20] and Benzie and Strain [21] respectively with some
modifications as reported previously [9].
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Quantification of the major phenolic compounds in the
aqueous rooibos extract was performed by high per-
formance liquid chromatography (HPLC) on an Agilent
1200 series instrument (Agilent Technologies, Waldbron,
Germany) equipped with an in-line degasser, quaternary
pump, autosampler and a diode array and multiple
wavelength detector, using a 5 μm YMC-Pack Pro C18
(150 mm × 4.6 mm i.d.) column for separation, with
acquisition set at 287 nm for aspalathin and 360 nm for
other components. The mobile phases consisted of
water containing 300 μL/L trifluoroacetic acid (A) and
methanol containing 300 μL/L trifluoroacetic acid (B).
The gradient elution started at 95% A, changing to 75%
A after 5 min and to 20% A after 25 min and back to
95% A after 28 min. The flow rate was set at 0.8 mL/
min, the injection volume was 20 μL and the column
temperature was set at 23°C [22]. Peaks were identified
based on the retention time of the standards and con-
firmed by comparison of the wavelength scan spectra
(set between 210 nm and 400 nm).
Animal treatment and experimental design
Forty pathogen-free, male Wistar rats weighing 287 ± 11 g
were obtained from the Animal Unit of Stellenbosch
University (Tygerberg Campus, South Africa). The rats
were housed individually in stainless steel wired top
and bottom cages fitted with polypropylene houses in
an experimental animal holding facility maintained at a
temperature of between 21-24°C, with a 12 h light dark
cycle. The rats were fed standard rat chow (SRC) ad
libitum and had free access to tap water or the aqueous
rooibos extract. After acclimatization for 1 week, the
rats were randomized into four groups of 10 animals
each, and treated for 28 days as follows: groups I
(control) and II (LPS), were fed SRC and received tap
water as the sole source of drinking fluid, while groups
III (rooibos) and IV (rooibos + LPS) were fed SRC and
received the aqueous rooibos extract (2%, w/v) as the
sole source of drinking fluid. On the 27th day of the
experiment, the rats were injected with either 0.1 mL
of PBS vehicle (groups I and III) or 0.1 mL of LPS
(Escherichia coli serotype 0111:B4, 0.5 mg/kg bw, i.p.)
for groups II and IV to induce endotoxemia and liver
injury [23]. Animals used in the study received humane
care in accordance with the Principle of Laboratory Ani-
mal Care of the National Medical Research Council and
the Guide for the Care and Use of Laboratory Animals of
the National Academy of Sciences (National Institute of
Health Publication no. 80-23, revised 1978). The study
protocol was approved by the Cape Peninsula University
of Technology’s Faculty of Health and Wellness Sciences
Research Ethics Committee (Ethics Certificate no: CPUT/
HAS-REC 2010/A003). The general conditions of the ratswere monitored daily throughout the study and body
weights recorded weekly and at sacrifice. Fluid intake was
monitored at intervals of 2 days for the duration of the
study period. At the end of the experimental period, fasted
animals in all the groups were sacrificed 16 hours after the
last LPS injection under sodium pentobarbital anesthesia
(0.15 ml/100 g body weight, i.p.). Approximately 8 ml of
blood was collected via the abdominal aorta and this was
aliquoted into tubes with or without EDTA to obtain
plasma or serum, respectively. The liver was excised,
washed twice with ice-cold PBS (10 mM phosphate
buffered saline pH 7.2) to remove residual blood, blotted
to dry, weighed and immediately snap frozen in liquid
nitrogen and stored at -80°C for biochemical analyses.
Preparation of liver homogenate
Liver tissue was minced and homogenized (10%, w/v)
in 50 mM NaH2PO4 buffer containing 1 mM EDTA
and 0.5% Triton-X (pH 7.5) on ice. The homogenate
was centrifuged at 10 000 g for 10 minutes at 4°C. The
resulting supernatant was collected and stored at -80°
C until used for biochemical assays. Protein contents
of samples (erythrocyte and liver homogenate) were
determined using a BCA protein assay kit (Pierce,
Illinois, USA).
Antioxidant capacity of plasma and liver homogenate
To avoid protein interference in the antioxidant capacity
assays, sub-samples of plasma and liver homogenates
were precipitated with 0.5 M perchloric acid (1:1, v/v) and
centrifuged at 10 000 g for 10 min at 4°C. Supernatants
were collected as protein free fractions [24]. Plasma total
polyphenol content, as well as the ORAC (plasma and
liver) were carried out according to the method of Single-
ton et al. [16] and Ou et al. [19], respectively.
Liver function tests
Serum ALT, AST and LDH were determined using stand-
ard diagnostic kits supplied by Medica Corporation,
(Bedford, Mass., USA), on a Medica EasyRA automated
clinical chemistry analyzer (Medica Corporation Bedford,
Mass., USA).
Lipid peroxidation, antioxidant enzymes activities and
glutathione status determination
Lipid peroxidation was estimated by measuring conjugated
dienes (CD) and malondialdehyde (MDA). Plasma and liver
MDA were assayed as MDA-TBA adducts using HPLC
with a UV-visible detector according to a method of
Khoschsorur et al. [25]. Results were expressed as μmole/L
or μmole/g tissue in plasma and liver respectively. Conju-
gated dienes were estimated according to the method of
Recknagel & Glende [26] and results expressed as nmole/L
or nmole/g tissue in plasma and liver respectively.
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erythrocytes and liver homogenates. Catalase (CAT) activ-
ity was determined according to the method described by
Aebi [27] in which the rate of decomposition of hydrogen
peroxide was measured at 240 nm. The activity of catalase
was calculated using a molar extinction coefficient of
43.6 M-1 cm-1 and results expressed as μmole H2O2
consumed/min/μg protein. The activity of superoxide
dismutase (SOD) was determined according to the
method of Crosti et al. [28] and activity expressed as
U/mg protein. Glutathione peroxidase (GPx) activity was
determined according to the method described by Ellerby
& Bredesen [29]. The activity of GPx was calculated using
the extinction coefficient of 6.22 mM-1 cm-1 and results
expressed as nmole NADPH oxidized per min per μg
protein. Glutathione reductase (GR) was assessed by
the method of Staal et al. [30] and result expressed as
μmole NADPH oxidized per min per μg protein using
the extinction coefficient of 6.22 mM-1 cm-1.
Hepatic and whole blood glutathione redox status
was measured using a Bioxytech GSH/GSSG-412™ kit
(OxisResearch™, Portland, USA). This method was based
on a method initially developed by Tietze [31] in which Ell-
man’s reagent (5,5’-dithiobis-2-nitrobenzoic acid, DTNB)
reacts with GSH to form a product spectrophotometrically
detected at 412 nm. Briefly, aliquots of whole blood
without (total glutathione) or with 3 mM freshly prepared
1-methyl-2-vinylpyridinium trifluoromethanesulfonate
(M2VP, oxidized glutathione) were precipitated with
5% (w/v) metaphosphoric acid (MPA). Liver samples
were homogenized (1:10) in 15% (w/v) trichloroacetic
acid (TCA) containing 1 mM EDTA for total glutathione
determination and in 6% (v/v) perchloric acid (PCA)
containing freshly prepared 3 mM M2VP and 1 mM
EDTA for oxidized glutathione (GSSG) determination
on ice. After centrifugation at 10 000 g for 10 min,
50 μl of supernatant (from deproteinized whole blood
or liver homogenate) was added to 50 μL of glutathione
reductase (1U) and 50 μL of 0.3 mM DTNB. The reac-
tion was initiated by addition of 1 mM NADPH to a
final volume of 200 μL. The change in absorbance was
monitored at 412 nm for 3 min and levels calculated
using pure GSH and GSSG as standards. Reduced
glutathione (GSH) concentration was calculated as the
difference between total glutathione and 2GSSG.
Multiplex cytokine analysis
Sub samples of livers were homogenized in 10 volumes
of phosphate buffered saline (10 mM PBS, pH 7.2) and
centrifuged twice at 15 000 g for 15 min at 4°C. The
level of four inflammatory markers TNF-α, IL-1β, IL-6
and IL-10 were determined in these homogenates using
customized Milliplex™ MAP rat cytokine kits (RCYTO-
80 K; Merck Millipore, St Charles, Missouri, USA), onthe Bio Plex platform (Bio Plex™, Bio Rad, Laboratories,
Hercules, USA) following the manufacturer’s instructions.
After optimizations, liver homogenates were assayed
undiluted, in a blinded manner. All analyte levels in the
quality control reagents of the kits were within the
expected ranges. The standard curve for all the analytes
ranged from 3.2-10000 pg/ml. The analyses of the bead
median fluorescence intensities were done using the
Bio-Plex Manager software (version 4.1.1).Statistical analysis
Values were expressed as mean ± SD. Data were tested
for normality and equality of variance using the Levene’s
Test. Differences between groups mean were estimated
using one-way analysis of variance (ANOVA) followed by
the Student-Newman-Keuls test for all pairwise compari-
sons. The Kruskal-Wallis test, a non-parametric analogue
to the one-way ANOVA was used to test for group differ-
ences when data was not normally distributed. Result were
considered statistically significant at p < 0.05, or marginally
significant at p < 0.1. All the statistics were carried out
using MedCalc v 12.2.1 software (MedCalc software bvba,
Mariakerke, Belgium).Results
Phenolic content and antioxidant capacity of aqueous
rooibos extract
Table 1 shows the results for the phenolic content and
in vitro antioxidant capacity of the fermented rooibos
extract used in the study. The total polyphenol content
is 1.06 mg GAE/mL (equivalent to 0.372 mg GAE/mg
soluble solids) of which the flavonols and flavanols account
for 45% and 17%, respectively. The antioxidant capacity of
the rooibos extract determined as ORAC, FRAP and TEAC
values are also shown in Table 1. Figure 1a shows the HPLC
profile of the aqueous fermented rooibos extract at 287 nm,
with aspalathin (29.98 ± 0.08 μg/mL) as the most abundant
flavonoid. Other major flavonoids include iso-orientin
(25.98 ± 0.52 μg/mL), orientin (18.61 ± 18.61 μg/mL),
hyperoside/rutin (14.55 ± 2.26 μg/mL), vitexin (6.07 ±
1.05 μg/mL), and iso-vitexin (7.18 ± 0.20 μg/mL). Minor
peaks corresponding to chrysoeriol, luteolin and quer-
cetin are also shown on the chromatogram (Figure 1b).Daily fluid and phenolic intake
The daily fluid and phenolic intake of normal and
endotoxemic rats are presented in Table 2. Fluid intake,
regardless of whether water or fermented rooibos was
consumed, was similar across all the animal groups.
Also total phenolic, flavonol and flavanol did not differ
in the two groups of animals consuming the fermented
rooibos.
Table 1 Phenolic content and in vitro antioxidant
capacity of aqueous rooibos extract
Aqueous rooibos extract
Constituents Concentration
Soluble solids (mg/mL) 2.85 ± 0.39
Total polyphenol (mg GAE/mL) 1.06 ± 0.02
Flavonol (mg QE/ mL) 0.48 ± 0.01
Flavanol (mg CE/mL) 0.19 ± 0.01
Aspalathin (μg/mL) 29.98 ± 0.08
Orientin (μg/mL) 18.61 ± 0.13
Iso-orientin (μg/mL) 25.98 ± 0.52
Vitexin (μg/mL) 6.07 ± 1.05
Iso-vitexin (μg/mL) 7.18 ± 0.20
Hyperoside/rutin (μg/mL) 14.55 ± 2.26
Quercetin (μg/mL) 0.89 ± 0.18
Luteolin (μg/mL) 0.22 ± 0.06
Chrysoeriol (μg/mL) 0.25 ± 0.01
ORAC (μmol AAE/mL) 1.69 ± 0.03
FRAP (μmol TE/mL) 5.20 ± 0.04
TEAC (μmol TE/mL) 4.79 ± 0.33
Values are mean ± SD. Soluble solid is a mean of 12 determinations while other
parameters are mean of 5 determinations. AAE (ascorbic acid equivalent),
CE (catechin equivalent), GAE (gallic acid equivalent), QE (quercetin equivalent),
TE (trolox equivalent).
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The effect of rooibos consumption on body weight gain,
liver weight, relative liver weight and serum levels of liver
function enzymes are depicted in Table 3. Consuming the
fermented rooibos extract without LPS treatment did not
have any adverse effect on any of the weight parameters,
as well as the serum levels of ALT, AST and LDH. No
mortality was recorded in the LPS-challenged groups
within the 16 hours before sacrifice. Intraperitoneal
injection of LPS did not have any adverse effect on the
body weight gain, liver weight or relative liver weight of
the rats when compared with the control rats. There
was a significant elevation (p < 0.05) in the serum levels
of ALT, AST and LDH with the LPS challenge when
compare to control rats, resulting in 56, 88 and 50%
significant (p < 0.05) increases, respectively. Consumption
of the fermented rooibos extract (with LPS challenge)
significantly (p < 0.05) reduced the elevation in serum
AST (21%) and LDH (28%), while serum ALT was
marginally (p < 0.1) reduced by 19% when compared
with rats injected with LPS only.
Plasma and liver antioxidant capacity and lipid
peroxidation markers
The antioxidant capacity of plasma and liver homogenates
were assessed as total polyphenol content and ORACvalues (Table 4). LPS injection significantly (p < 0.05)
reduced the plasma total polyphenol content, with rooibos
supplementation able to reverse this reduction to a level
comparable to that of the control. The plasma and liver
ORAC of rats challenged with LPS were not significantly
different (p > 0.05) from that of the control rats, regardless
of whether the animals were consuming rooibos or not.
Table 4 also shows the effect of the fermented rooibos
extract supplementation on plasma and hepatic lipid
peroxidation in normal and endotoxemic rats. Lipid per-
oxidation was assessed as conjugated dienes (CD) and
malondialdehyde (MDA) formation. Plasma and hepatic
CDs were similar across all groups of animals. MDA levels
were significantly (p < 0.05) elevated in the plasma (22%)
and liver (43%) of LPS rats compared with control rats.
In LPS-challenged rats consuming the fermented rooibos
extract, the plasma and hepatic elevation in MDA was sig-
nificantly (p < 0.05) reduced by 27 and 22%, respectively.Antioxidant enzymes and glutathione status
The effect of aqueous fermented rooibos extract consump-
tion on antioxidant enzyme activities and glutathione redox
status in the blood and liver of control and LPS-treated rats
are shown in Table 5. In the erythrocytes, SOD and CAT
activities were not affected by LPS injection. However,
the activities of GPx and GR were significantly (p < 0.05)
reduced in the LPS-treated rats when compared with
the control rats. Consuming the aqueous rooibos extract
marginally (p < 0.1) increased the GPx and GR activities in
the LPS-challenged rats. Hepatic SOD and GPx activities
were significantly (p < 0.05) decreased, while CAT activity
was significantly (p < 0.05) increased as a result of the LPS
challenge. Consumption of fermented rooibos extract in
LPS-challenged rats significantly (p < 0.05) reversed the
changes induced in hepatic SOD, CAT and GPx activities.
In the blood, the LPS challenge resulted in a significantly
(p < 0.05) increased GSSG level of 18%, while depleting
the GSH level as well as the GSH: GSSG ratio by 34
and 39%, respectively, when compared to the control
rats. Consumption of the fermented rooibos extract in
LPS-challenged rats restored the GSH and GSH: GSSG
ratio to levels comparable to those of the control rats,
while not showing any effect on GSSG levels. Although,
hepatic GSH levels were not affected by the LPS challenge
in the LPS only rats when compared to the control rats,
hepatic GSSG levels were significantly (p < 0.05) elevated.
As a result, a significant (p < 0.05) decrease in hepatic
GSH: GSSG ratio was observed in the LPS only rats
when compared to the control rats. Aqueous rooibos
extract consumption in the LPS treated rats significantly
reduced the elevation in GSSG and improved the GSH:
GSSG ratio to values similar to those found in the control
rats.
Figure 1 HPLC chromatogram of fermented rooibos extract used in the study showing (a) peak 1 for aspalathin at 287 nm (b) peaks
for other flavonoids. 1, orientin; 2, iso-orientin; 3, vitexin; 4, isovitexin; 5, hyperoside/rutin; 6, quercetin; 7, luteolin; 8, chrysoeriol; at 360 nm.
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Table 2 Daily fluid and phenolic intakes of control and experimental rats
Treatment Water/Rooibos intake/
day/100 g BW (mL)
Total phenolic intake
(mg GAE/day/100 g BW)
Flavonol intake
(mg QE/day/100 g BW)
Flavanol intake
(mg CE/day/100 g BW)
Control 10.44 ± 1.06 ND ND ND
LPS 10.68 ± 0.76 ND ND ND
Rooibos 9.86 ± 0.88 10.45 ± 0.93 4.20 ± 0.38 1.59 ± 0.14
Rooibos + LPS 9.92 ± 0.49 10.51 ± 0.52 4.23 ± 0.21 1.60 ± 0.08
Calculations of the total phenolic, flavonol and flavanol intakes were calculated based on the soluble solid intake obtained from the average rooibos consumption
per day. Values are mean ± SD (n = 10). ND (not determined), BW (body weight), CE (catechin equivalent), GAE (gallic acid equivalent), QE (quercetin equivalent),
LPS (lipopolysaccharide).
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Figure 2 shows the effect of the aqueous fermented rooibos
extract consumption on hepatic cytokine levels in normal
and LPS-treated rats. A significant (p < 0.05) increase in
the levels of TNF-α (45%), IL-1β (419%) and IL-6 (37%)
(Figures 2a, 2b and 2c, respectively) were observed in
the liver of LPS-treated rats compared to control rats.
Consuming the fermented rooibos extract significantly
(p < 0.05) reduced the LPS-induced elevation in TNF-α
and IL-6 to levels comparable to those observed in the
negative control rats, however, no effect was seen in the
IL-1β levels of LPS rats that consumed the rooibos
extracts. The hepatic levels of the anti-inflammatory
cytokine IL-10 (Figure 2d) was similar across all treat-
ment groups, including the rooibos as well as the LPS
and control groups.
Discussion
The focus of this study was to investigate the acute
effects of LPS-induced hepatic oxidative stress and
inflammatory responses, and the possible protection
offered by oral administration of an aqueous fermented
rooibos extract. The liver plays an important and central
role in the regulation of entry and metabolism of LPS
upon exposure. Mostly, the hepatic and systemic toxicities
of LPS have been attributed to the release of chemical
mediators such as superoxide, nitric oxide and pro-
inflammatory cytokines, including TNF-α, IL-1β and
IL-6, which are all formed as a result of the binding of
LPS to the CD14/LPS-binding protein and Toll-like
receptor-4 (TLR4) on the surface of Kupffer cells [3,32].Table 3 Effects of rooibos supplementation on weight param
Treatment Control LPS
Weight gain (g) 89.21 ± 17.31 91.19 ± 1
Liver weight (g) 11.83 ± 0.82 12.36 ± 1
RLW (%) 3.15 ± 0.22 3.36 ± 0.4
ALT (U/L) 105.69 ± 28.93 165.29 ±
AST (U/L) 88.98 ± 12.53 167.22 ±
LDH (U/L) 234.92 ± 74.55 351.36 ±
Values are mean ± SD (n = 9-10). *Significantly different from control (p < 0.05). #Sig
ALT (alanine aminotransferase), AST (aspartate aminotransferase), LDH (lactate dehyOxidative stress is a well-known mechanism of LPS-
induced hepatic injury, and the redox imbalance produced
may result in depletion of endogenous antioxidants such
as the antioxidant enzymes and alteration of GSH redox
status. Thus, augmenting the antioxidant defense system
becomes necessary, especially during infections or periods
of chronic oxidative insult. Whole extracts or isolated
compounds from plants are popular applications to
reverse and/or prevent hepatotoxicity and oxidative
stress produced by noxious agents, such as LPS and these
beneficial effects may be attributed to their antioxidant
and anti-inflammatory properties.
In this study, it was observed that a single injection of
LPS did not have a negative effect on the body weight
gain, absolute liver weight and relative liver weight of
the rats. However, LPS injection resulted in hepatic
injury as indicated by an elevation in the levels of
serum ALT, AST, and LDH, all circulating markers of
hepatocyte injury. The hepatic function marker enzymes
are cytoplasmic in nature but are usually leaked into
circulation when liver damage occurs due to an alteration
in membrane permeability. This observation is in accord-
ance with several earlier reports which have shown that
LPS induces hepatic damage, and as a consequence,
increases the level of serum aminotransferases [33-35].
Results from the current study showed that supplemen-
tation with the aqueous fermented rooibos extract for
4 weeks prior to the LPS challenge, reversed the induced
damage in the liver. Previous reports have demonstrated
the ability of some polyphenol-rich plant extracts such as
Artemisia absinthium [36], Salvia plebeia [37], Eucalyptuseters and serum marker enzymes in all experimental rats
Rooibos Rooibos + LPS
1.57 90.01 ± 3.53 91.61 ± 6.20
.25 12.42 ± 1.25 12.64 ± 0.65
3 3.27 ± 0.25 3.30 ± 0.14
39.60* 109.31 ± 11.32 133.95 ± 39.60##
34.82* 82.98 ± 9.91 131.64 ± 33.92#
81.64* 219.22 ± 58.16 252.67 ± 76.62#
nificantly different from LPS (p < 0.05). ##Marginally different from LPS (p < 0.1).
drogenase), LPS (lipopolysaccharide), RLW (relative liver weight).
Table 4 The effect of rooibos supplementation on in vivo total antioxidant capacity and markers of lipid peroxidation
in plasma and liver of all experimental rats
Tissue Parameter Control LPS Rooibos Rooibos + LPS
Plasma Total polyphenol 96.69 ± 9.49 73.37 ± 6.83* 91.94 ± 8.49 85.69 ± 12.24#
ORAC 1791.67 ± 167.21 1499.48 ± 375.47 1842.11 ± 345.04 1708.30 ± 528.84
CD 85.79 ± 5.81 88.40 ± 8.56 84.34 ± 10.66 85.11 ± 8.17
MDA 1.96 ± 0.21 2.40 ± 0.20* 1.79 ± 0.25 1.76 ± 0.32#
Liver ORAC 19.06 ± 4.33 17.40 ± 4.14 21.98 ± 3.27 18.51 ± 4.50
CD 10.38 ± 1.12 12.78 ± 0.79 11.62 ± 0.62 11.84 ± 0.47
MDA 64.83 ± 5.46 92.65 ± 7.57* 64.44 ± 7.57 72.27 ± 7.79#
Values are mean ± SD (n = 9-10) *Significantly different from control (p < 0.05). #Significantly different from LPS (p < 0.05). CD (conjugated dienes; nmole/L in
plasma, nmole/g tissue in liver), MDA (malondialdehyde; μmole/L in plasma, μmole/g tissue in liver), LPS (lipopolysaccharide), ORAC (oxygen radical absorbance
capacity; μmole trolox equivalent/L in plasma, μmole trolox equivalent/g tissue in liver), Total polyphenol (μmole gallic acid equivalent/L).
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http://www.biomedcentral.com/1472-6882/14/392globulus [38] and Hibiscus sabdariffa [39] in ameliorating
LPS-induced hepatic injury. The protective effect of
rooibos extract observed in our study may be due to the
ability of the flavonoids in rooibos to stabilize and main-
tain the integrity of the hepatocyte membrane, as well as
repair damaged hepatic tissues by stimulating hepatocyte
regeneration and hepatocellular protein synthesis.
Results from a previous study have shown activation
of Kupffer cells during endotoxemic episodes to result in
the secretion of a wide variety of cytokines, including
TNF-α, IL-1β and IL-6 [40]. Up-regulation of cytokine
production during LPS-induced endotoxemia is a well-
known phenomenon, and evidence has shown that
increased levels of pro-inflammatory cytokines from
neutrophils in the liver were associated with liver cellTable 5 The effect of rooibos supplementation on antioxidan
blood and liver of all experimental rats
Tissue Parameter Control LP
Blood CAT 0.21 ± 0.05 0.
SOD 22.35 ± 3.82 22
GR 0.15 ± 0.01 0.
GPx 0.18 ± 0.03 0.
GSH 906.11 ± 173.54 59
GSSG 173.47 ± 34.25 20
GSH:GSSG 4.76 ± 1.22 2.
Liver CAT 0.11 ± 0.01 0.
SOD 55.01 ± 5.27 42
GR 3.99 ± 1.12 2.
GPx 0.16 ± 0.02 0.
GSH 6.38 ± 0.58 6.
GSSG 0.32 ± 0.10 0.
GSH:GSSG 21.42 ± 6.32 13
Values in columns are mean ± SD (n = 9-10). *Significantly different from control (P <
LPS (p < 0.1). CAT (catalase, μmole H2O2 consumed/min/μg protein), GR (glutathion
dismutase, U/mg protein), GPx (glutathione peroxidase, nmole NADPH oxidized/min
liver), GSSG (oxidized glutathione, μmole/L in blood, μmole/g tissue in liver), LPS (lipdamage [41]. Tumor necrosis factor-α, and IL-6 are two
key cytokines involved in tissue damage during sepsis,
although it has been suggested that TNF-α is the central
mediator regulating other subsequent events [42]. In the
present study, LPS significantly increased the level of
hepatic TNF-α, IL-1β and IL-6. Feeding rooibos for
4 weeks prior to the LPS challenge was able to reverse
the increase in TNF-α and IL-6 observed in the liver to a
level that was comparable to what was seen in untreated
control animals. However, no reversal was seen in the
level of IL-1β with rooibos extract supplementation.
Although Hendricks & Pool [13], in an in vitro study
reported that rooibos tea induced a higher IL-6 and a
lower IL-10 when added to endotoxin-stimulated white
blood cells, literature supporting the inhibition of cytokinest enzymes activity and glutathione redox status in the
S Rooibos Rooibos + LPS
22 ± 0.02 0.27 ± 0.04 0.20 ± 0.04
.25 ± 3.25 25.46 ± 3.30 19.24 ± 1.72
09 ± 0.04* 0.15 ± 0.03 0.12 ± 0.05##
14 ± 0.02* 0.23 ± 0.03 0.16 ± 0.03##
6.04 ± 135.59* 905.09 ± 135.20 862.60 ± 112.25#
5.29 ± 8.69* 185.45 ± 35.99 202.92 ± 17.52
90 ± 0.65* 5.18 ± 1.86 4.27 ± 0.59#
23 ± 0.03* 0.11 ± 0.03 0.16 ± 0.03#
.06 ± 6.26* 61.50 ± 3.85 57.62 ± 6.92#
69 ± 0.62 3.80 ± 0.80 3.37 ± 0.79
12 ± 0.02* 0.16 ± 0.01 0.15 ± 0.01#
37 ± 0.83 7.29 ± 0.96 7.41 ± 0.75
46 ± 0.09* 0.28 ± 0.04 0.35 ± 0.08#
.64 ± 2.39* 25.64 ± 4.66 21.98 ± 5.34#
0.05). #Significantly different from LPS (p < 0.05). ##Marginally different from
e reductase, μmole NADPH oxidized/min/μg protein), SOD (superoxide
/μg protein). GSH (reduced glutathione, μmole/L in blood, μmole/g tissue in
opolysaccharide).
Figure 2 Effect of aqueous fermented rooibos extract supplementation on hepatic (a) TNF-α (b) IL-1β (c) IL-6 and (d) IL-10 levels in
normal and endotoxemic rats. Bars represent mean ± SD (n = 8-10). *Significantly different from control at p < 0.05. #Significantly different from
LPS at p < 0.05. LPS (lipopolysaccharide).
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that the protective effect shown by rooibos on cytokine
formation in this study may be due to the plethora of
antioxidant phytochemicals found in rooibos, since previ-
ous reports have shown that flavonoids found in rooibos
such as luteolin, rutin and quercetin reduced LPS-induced
expression of cytokines [43,44]. We also propose that
the mechanism for the observed reduction in hepatic
TNF-α and IL-6 may involve the ability of antioxidant
phytochemicals present in rooibos to inhibit the activation
of Kupffer cells by LPS, leading to inhibition of TNF-α
synthesis and subsequently synthesis of IL-6. Though the
level of nuclear factor- κB (NF-κB) was not measured
in this study, given its central role in signaling and the
inflammatory cascade, it is proposed that inhibiting the
activation of NF-κB by rooibos, may be an additional
mechanism for the observed decrease in hepatic TNF-α
and IL-6 level. IL-10 is an anti-inflammatory cytokine
produced by monocytes and lymphocytes, while previous
reports have indicated that it is antagonistic to TNF-α in
its modulation of the inflammatory response [45]. IL-10
has been reported to down-regulate TNF-α, as well as
other cytokine production, by suppressing their gene
expression in an autocrine-like feedback loop [46].
However in this study, we observed that the level of IL-10
was similar across all control and LPS-treated groups,indicating that the inhibition of TNF-α formation observed
with rooibos extract supplementation may be independent
of the activation of the feedback loop of IL-10.
Nitric oxide (NO) and superoxide anion (O2
•−) are
two free radicals secreted during activation of Kupffer
cells under LPS insult. NO reacts with O2
•− to form
peroxynitrite which is a potent cytotoxic, oxidative agent
that can elicit lipid peroxidation [47]. LPS-induced lipid
peroxidation is an index of oxidative stress, and several
previous studies have reported enhanced lipid peroxida-
tion in many tissues (including liver, heart, brain, small
intestine and stomach) of rats [2,33-35,48]. Under condi-
tions of oxidative stress, reactive oxygen and nitrogen
species (RONS) attack the polyunsaturated fatty acids
(PUFAs) of cell membranes causing destabilization, dis-
integration and alteration in membrane fluidity and
permeability, all events which increase the rate of protein
degradation and eventually leads to cell lysis [40]. Decom-
position products of lipid hydroperoxides such as MDA
and 4-HNE can also cause chaotic cross-linkage with
protein and nucleic acids, leading to oxidative protein
and DNA damage [49]. In this study, plasma and hepatic
CD and MDA, as markers of lipid peroxidation, were
measured. While plasma and hepatic CD were unaffected
by LPS treatment, elevated levels of plasma and hepatic
MDA were observed. Pre-feeding rooibos extract for
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tion of MDA in the plasma and liver. A large number of
in vitro studies have established the excellent free radical
scavenging ability of rooibos, and this has been confirmed
in many in vivo studies. The ability of rooibos to lower
lipid peroxidation and modulate oxidative stress has been
demonstrated in rat brain [50], liver [9,51,52], as well as in
humans at risk [10,11]. Since rooibos is a polyphenol-rich
herbal tea, its polyphenolic compounds may be able to
bind RONS directly and scavenge them or act as sacrificial
antioxidants to inhibit the lipid peroxidation cascade as
seen in this study.
The impairment of the antioxidant defense system is a
critical step in LPS-induced hepatic injury. Evidence has
shown that a LPS insult is characterized by change in
tissue and circulating antioxidant enzymes levels, as well
as non-enzymatic antioxidants, including GSH [33,34,40].
In our study, plasma SOD and CAT were unaffected by
LPS treatment, while activities of GPx and GR were
significantly reduced. In the liver, the activity of SOD
was inhibited by LPS treatment. This inhibition is not
surprising since the O2
•− has been implicated as one of
the toxic mediators responsible for most toxicities
observed in LPS-induced cellular injury, and SOD, a
metalloprotein, is a key enzyme involved in the protection
of cells by spontaneously dismutating O2
•− to H2O2. The
H2O2 produced by SOD is usually decomposed to water
and oxygen by the hemoprotein CAT, localized in the
peroxisomes. LPS treatment significantly increased the
activity of hepatic CAT in this study. An increase that may
be an adaptive physiological response to overproduction
of H2O2 resulting from SOD action. GPx and GR are
important enzymes of the glutathione defense system.
While GPx catalyses the reduction of H2O2 and lipid
hydroperoxides using GSH as a co-substrate, GR regen-
erates GSH from GSSG at the expense of NADPH. In
this study, the activities of both GPx and GR were
significantly depleted by LPS treatment, an indication of
their inactivation and failure of the antioxidant enzymes
to overcome the influx of RONS after LPS exposure
[53]. Results from this study further showed that feeding
rooibos for 4 weeks prior to the LPS challenge reversed
the changes observed in the activities of SOD, CAT, GPx
and GR in the liver. The modulation of the antioxidant
enzymes activities observed in the LPS-challenged rats
consuming rooibos could be ascribed to the direct
quenching of RONS generated by LPS, since antioxidant
components of rooibos are established free radical
scavengers. Furthermore, the up-regulation and/or down-
regulation of the gene expression of the antioxidant
enzymes may be an additional mechanism that should
be elucidated in future studies. Reduced glutathione
(GSH) is the major non-protein thiol in plant and animal
cells. It is essential for the regulation of a variety of cellularfunctions, playing an important role in intracellular
protection against ROS and other free radicals [54].
Because of its sulphydryl (–SH) group, it can function as a
nucleophile, forming conjugates with many xenobiotics
and/or their metabolites and also serve as a reductant
in the metabolism of hydrogen peroxide and other organic
peroxides [55]. During interaction with free radicals,
the –SH group of GSH becomes oxidized, leading to the
formation of corresponding disulfide compound (GSSG).
Thus, a depletion of GSH is usually associated with an
increase in GSSG concentration and a lowered GSH:
GSSG redox ratio during conditions of oxidative stress
[56,57]. Results from the current study revealed a decrease
in GSH (blood) and an increase in GSSG (liver) in rats
challenged with LPS. These events invariably resulted
in a decrease in the GSH:GSSG ratio in both tissues of
LPS-challenged rats. Feeding rooibos to LPS-treated
rats, restored the GSH:GSSG ratio to values comparable
to those found in the negative control animals, indicating
that rooibos extract is able to protect against LPS-induced
glutathione imbalance. The protection shown by rooibos
in this study is in agreement with previous studies where
rooibos has been reported to improve the GSH:GSSG
ratio in rat hearts subjected to ischaemia/reperfusion
injury [58], rats oxidatively challenged with t-BHP [9]
and human populations at the risk for cardiovascular
diseases [11]. The ability to improve the GSH: GSSG
ratio via increasing GSH (plasma) and/or decreasing
GSSG (liver), shown by rooibos can be ascribed to the
ability of their individual antioxidant components to
quench free radicals and up-regulate the synthesis of
GSH as suggested in some previous studies [59].
It is important to point out that since this study was
conducted in male rats, it is possible that the results
obtained may or may not be applicable to female rats.
Several reports have shown gender-related differences
in liver damage after various types of insults [60,61].
Some studies in animals reported a sex-related difference
to oxidative stress and activities of cellular antioxidant
enzymes which may be organ specific [62-64]. These
studies showed that female animals may be less susceptible
to oxidative stress-induced liver injury compared to male
animals. Though gender-related differences in susceptibility
to xenobiotic-induced liver injury is controversial and its
specific mechanism(s) is still not fully understood, differ-
ences in circulating sex hormones, hepatic expression of
sex hormone receptors and pattern of growth hormone
secretion have all been mentioned to be responsible [61].
Conclusion
This study provides the first in vivo evidence of an anti-
inflammatory effect of rooibos in LPS-induced hepatic
injury in rats. LPS-induced cytokine secretion has been
shown to require the production of reactive oxygen and
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onstrated in this study. Results from this study further
demonstrates that rooibos is able to suppress LPS-
triggered oxidative stress and inflammatory responses in
the liver by attenuating liver damage, lipid peroxidation,
redox (GSH:GSSG) imbalance and pro-inflammatory
cytokine secretion in a Wistar rat model. Rooibos contain
important phytochemical constituents with excellent anti-
oxidant properties which may in part, explain this
observed anti-inflammatory activity. This suggest that
rooibos may be of benefit in the prophylactic manage-
ment of LPS-induced liver injury, however, future studies
are necessary to fully examine the specific mechanisms
underlying the protective effects shown by this herbal tea.
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